Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
Complement activation protects against infection but also contributes to pathological mechanisms in a range of clinical conditions such as autoimmune diseases and transplant rejection. Complement-inhibitory drugs, either approved or in development, usu…